HUB's blog

Dnyanada Sahasrabudhe

The KRAS Conundrum: Challenges and strategies for targeted therapies in cancer

The KRAS Conundrum: Challenges and strategies for targeted therapies in cancer

Published by Dnyanada Sahasrabudhe on Jul 23, 2024

KRAS is a proto-oncogene that is crucial in regulating cell growth and division. Mutations in the KRAS gene are commonly found in various cancers, including colorectal pancreatic, and lung cancers. These mutations can lead to the constitutive activation of the RAS signaling pathway, promoting ...

read more

Do you need a license to work with HUB Organoid® Technology?

Do you need a license to work with HUB Organoid® Technology?

Published by Dnyanada Sahasrabudhe on Jul 7, 2022

Explore HUB’s license offerings and how they apply to your organoid ...

read more

Forecasting a champion: How HUB Organoids® can speed up the drug development timeline to about five years

Forecasting a champion: How HUB Organoids® can speed up the drug development timeline to about five years

Published by Dnyanada Sahasrabudhe on May 17, 2022

Learn why you should invest in patient-derived HUB Organoids® for ...

read more